Homogeneous Bioassay Using Long-Lifetime Donor for Signal Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current homogeneous bioassays face limitations in sensitivity and specificity due to interference from biological sample matrices and optical properties, particularly in measuring biological activity or analyte concentration, as they rely on conventional fluorophores and suffer from high background signals and autofluorescence.
Innovation Solution
A luminescence energy transfer-based homogeneous bioassay is developed, utilizing a combination of a short-lifetime fluorescent acceptor, a quencher, and a long-lifetime or up-conversion fluorescent donor, where the distance between the acceptor and quencher increases upon cleavage, allowing for enhanced signal detection through energy transfer from the donor to the acceptor, independent of donor and acceptor concentrations, and capable of measuring in strongly colored samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional fluorophores are used in homogeneous bioassays, then the assay can be performed without separation steps, but the sensitivity and specificity are limited due to high background signals and autofluorescence from biological sample matrices
Solution Approach 1:
The patent changes the temporal parameter of fluorescence emission by using long-lifetime fluorescent donors (microsecond to millisecond range) instead of conventional short-lifetime fluorophores. This allows time-resolved detection that separates the assay signal from the background autofluorescence, which has shorter lifetime characteristics. The invention also introduces up-conversion fluorescent compounds that convert low-energy excitation light to high-energy emission, enabling detection in wavelength regions with minimal sample matrix interference.
Solution Approach 2:
The patent introduces an energy transfer intermediary system where a long-lifetime fluorescent donor transfers energy to a fluorescent acceptor through Förster resonance energy transfer (FRET). This intermediary energy transfer mechanism allows the assay to detect binding events indirectly through changes in energy transfer efficiency, while the long-lifetime donor provides temporal resolution to eliminate background interference. The FRET pair acts as a mediator that converts molecular proximity information into measurable luminescence signals.
2Measurement precision
If long-lifetime fluorescent donors are used to improve signal-to-background ratio, then background interference is reduced, but the complexity of the assay system increases due to multiple components required for energy transfer
Solution Approach 1:
The patent merges multiple functions into a single molecular construct by creating a tri-component system where the donor, acceptor, and target analyte are brought into close proximity through specific binding interactions. This merging allows the energy transfer process to occur within a confined spatial and temporal window, simplifying the detection mechanism. The invention also combines the binding recognition function and the fluorescence signaling function into an integrated assay format where the binding event directly modulates the energy transfer efficiency.
Solution Approach 2:
The assay system utilizes the intrinsic properties of the fluorescent components to generate the detection signal without requiring external separation or purification steps. The long-lifetime donor automatically provides temporal discrimination against background autofluorescence, and the FRET mechanism automatically reports molecular proximity changes. The system serves itself by using the binding event to directly modulate the fluorescence signal through changes in energy transfer efficiency, eliminating the need for additional mechanical or chemical processing steps.
3Adaptability or versatility
If up-conversion fluorescent compounds are used as donors, then detection in strongly colored samples is enabled, but the cost and availability of specialized reagents increase
Solution Approach 1:
The patent transitions from detecting fluorescence in the visible spectrum to using up-conversion fluorescent compounds that emit in the visible range while being excited by infrared or near-infrared light. This dimensional change in the energy spectrum allows the assay to bypass absorption by colored sample matrices, as infrared light penetrates turbid and colored samples more effectively. The invention exploits the unique optical properties of up-conversion materials to access a new spectral dimension that is less affected by sample matrix interference.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves signal-to-background ratio, enables detection of small amounts of cleaved substrates, and allows for real-time monitoring of biological activity without interference from sample matrices, using particulate donors to efficiently transfer fluorescence to a single acceptor, thus overcoming limitations of conventional methods.
Implementation Method 1
a luminescence energy transfer-based homogeneous bioassay
Implementation Method 2
a second group comprising a quencher, which quencher is capable of energy transfer from an acceptor
Data Source
AI summary
A homogenous bioassay including i) a first group containing a short lifetime fluorescent acceptor, and ii) a second group containing a quencher, with the first and second groups linked by at least a first linkage. The bioassay measures the acceptor's fluorescence increase resulting from cleavage of the first linkage and also includes iii) a third group containing a donor for energy transfer to the acceptor, where the donor is an up-conversion fluorescent compound, a long-lifetime fluorescent compound or an electrogenerated luminescent compound. A conformational or terminal epitope is created on the first group through linkage cleavage, and the third group includes a binder with affinity for this epitope. The acceptor's fluorescence is caused by exciting the donor. Also disclosed are bioassay kits for this method.